Literature DB >> 19660719

Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.

Yi-Bin Chen1, Haesook T Kim, Sean McDonough, Robert D Odze, Xiaopan Yao, Suzan Lazo-Kallanian, Thomas R Spitzer, Robert Soiffer, Joseph H Antin, Jerome Ritz.   

Abstract

Acute graft-versus-host disease (aGVHD) is a major complication after hematopoietic stem cell transplantation (HSCT). The pathophysiology of aGVHD involves priming of naïve donor T cells in host secondary lymphoid tissue, followed by migration of effector T cells to target organs. Mediators of lymphocyte trafficking are believed to play a significant role in this migration. In this retrospective case-controlled study, we analyzed the expression of alpha4beta7 integrin and CCR9, 2 surface T cell molecules specific for intestinal trafficking, from blood samples collected previously from 59 patients after HSCT (20 without aGVHD, 20 with skin aGVHD, and 19 with intestinal aGVHD). All samples had been obtained before the onset of aGVHD symptoms (with 1 sample collected on the day of symptom onset). Analysis by flow cytometry demonstrated that alpha4beta7 integrin was significantly increased on both naïve and memory T cells in patients who subsequently developed intestinal aGVHD, with the most significant differences observed in memory subsets. Immunohistochemical staining on rectal biopsy specimens from patients with intestinal aGVHD showed that expression of alpha4beta7 integrin was concentrated on mononuclear cells in blood vessels within the intestinal mucosa. These results suggest that alpha4beta7 integrin likely is involved in lymphocyte trafficking in intestinal aGVHD and may have potential clinical use as a correlative biomarker or as a target for the treatment and prophylaxis of intestinal aGVHD after HSCT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660719      PMCID: PMC2945817          DOI: 10.1016/j.bbmt.2009.05.003

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  45 in total

Review 1.  Chemokines and cell migration in secondary lymphoid organs.

Authors:  J G Cyster
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs.

Authors:  Andreas Beilhack; Stephan Schulz; Jeanette Baker; Georg F Beilhack; Ryosei Nishimura; Enosh M Baker; Gilad Landan; Edward I Herman; Eugene C Butcher; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

3.  Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.

Authors:  Elisha Waldman; Sydney X Lu; Vanessa M Hubbard; Adam A Kochman; Jeffrey M Eng; Theis H Terwey; Stephanie J Muriglan; Theo D Kim; Glenn Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

4.  Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.

Authors:  Markus Y Mapara; Corinna Leng; Yong-Mi Kim; Roderick Bronson; Anna Lokshin; Andrew Luster; Megan Sykes
Journal:  Biol Blood Marrow Transplant       Date:  2006-06       Impact factor: 5.742

Review 5.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

Authors:  G R Hill; J L Ferrara
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

6.  A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy.

Authors:  I Yakoub-Agha; P Saule; S Depil; J-B Micol; C Grutzmacher; F Boulanger-Villard; F Bauters; J-P Jouet; J-P Dessaint; M Labalette
Journal:  Leukemia       Date:  2006-07-06       Impact factor: 11.528

7.  CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.

Authors:  Karen P Piper; Claire Horlock; S John Curnow; Julie Arrazi; Sarah Nicholls; Premini Mahendra; Charles Craddock; Paul A H Moss
Journal:  Blood       Date:  2007-08-31       Impact factor: 22.113

8.  Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells.

Authors:  Britt E Anderson; Patricia A Taylor; Jennifer M McNiff; Dhanpat Jain; Anthony J Demetris; Angela Panoskaltsis-Mortari; Ann Ager; Bruce R Blazar; Warren D Shlomchik; Mark J Shlomchik
Journal:  Blood       Date:  2008-02-19       Impact factor: 22.113

9.  CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.

Authors:  Husein Hadeiba; Tohru Sato; Aida Habtezion; Cecilia Oderup; Junliang Pan; Eugene C Butcher
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

10.  Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis.

Authors:  B A Zabel; W W Agace; J J Campbell; H M Heath; D Parent; A I Roberts; E C Ebert; N Kassam; S Qin; M Zovko; G J LaRosa; L L Yang; D Soler; E C Butcher; P D Ponath; C M Parker; D P Andrew
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  21 in total

1.  An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

Authors:  Matthew J Hartwell; Umut Özbek; Ernst Holler; Anne S Renteria; Hannah Major-Monfried; Pavan Reddy; Mina Aziz; William J Hogan; Francis Ayuk; Yvonne A Efebera; Elizabeth O Hexner; Udomsak Bunworasate; Muna Qayed; Rainer Ordemann; Matthias Wölfl; Stephan Mielke; Attaphol Pawarode; Yi-Bin Chen; Steven Devine; Andrew C Harris; Madan Jagasia; Carrie L Kitko; Mark R Litzow; Nicolaus Kröger; Franco Locatelli; George Morales; Ryotaro Nakamura; Ran Reshef; Wolf Rösler; Daniela Weber; Kitsada Wudhikarn; Gregory A Yanik; John E Levine; James Lm Ferrara
Journal:  JCI Insight       Date:  2017-02-09

2.  Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

Authors:  George B McDonald; Laura Tabellini; Barry E Storer; Paul J Martin; Richard L Lawler; Steven L Rosinski; H Gary Schoch; John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-03       Impact factor: 5.742

3.  Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Jianwei Zheng; Brian Taylor; Joseph Dodge; Allison Stephans; Song Guo Zheng; Qiang Chen; Xiao Chen
Journal:  Am J Transplant       Date:  2019-07-15       Impact factor: 8.086

4.  Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomes.

Authors:  B G Engelhardt; M Jagasia; B N Savani; N L Bratcher; J P Greer; A Jiang; A A Kassim; P Lu; F Schuening; S M Yoder; M T Rock; J E Crowe
Journal:  Bone Marrow Transplant       Date:  2010-05-31       Impact factor: 5.483

Review 5.  Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.

Authors:  S C Nalle; J R Turner
Journal:  Mucosal Immunol       Date:  2015-05-06       Impact factor: 7.313

Review 6.  Graft-versus-host disease biomarkers: omics and personalized medicine.

Authors:  Sophie Paczesny; Nisha Raiker; Sam Brooks; Christy Mumaw
Journal:  Int J Hematol       Date:  2013-09       Impact factor: 2.490

7.  A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease.

Authors:  Xiao Chen; Joseph Dodge; Richard Komorowski; William R Drobyski
Journal:  Blood       Date:  2013-03-25       Impact factor: 22.113

8.  Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

Authors:  Brian G Engelhardt; Salyka M Sengsayadeth; Madan Jagasia; Bipin N Savani; Adetola A Kassim; Pengcheng Lu; Yu Shyr; Sandra M Yoder; Michael T Rock; James E Crowe
Journal:  Exp Hematol       Date:  2012-08-10       Impact factor: 3.084

9.  Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus.

Authors:  M J McElrath; K Smythe; J Randolph-Habecker; K R Melton; T A Goodpaster; S M Hughes; M Mack; A Sato; G Diaz; G Steinbach; R M Novak; Marcel E Curlin; M Curlin; J D Lord; J Maenza; A Duerr; N Frahm; Florian Hladik
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

Review 10.  Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.

Authors:  Sophie Paczesny; Christine Duncan; David Jacobsohn; Robert Krance; Kathryn Leung; Paul Carpenter; Catherine Bollard; Jamie Renbarger; Kenneth Cooke
Journal:  Proteomics Clin Appl       Date:  2014-10-30       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.